Multidrug-resistant Streptococcus pneumoniae strains have emerged over the past decade at an alarming rate. The molecular mechanism of trimethoprim resistance was investigated in 5 pneumococcal strains isolated in the Washington, DC, area from patients with invasive infections. Cloning and sequencing of the trimethoprim resistance determinant from these pneumococci indicated that an altered chromosome-encoded dihydrofolate reductase (DHFR) was responsible for the observed resistance. Comparison of DHFR sequences from pneumococcal strains with various susceptibilities to trimethoprim, together with site-directed mutagenesis, revealed that substitution of isoleucine-100 with a leucine residue resulted in trimethoprim resistance. Hydrogen bonding between the carbonyl oxygen of isoleucine-100 and the 4-amino group of trimethoprim is proposed to play a critical role in the inhibition of DHFR by trimethoprim. This enzyme-substrate model should facilitate the design of new antibacterial agents with improved activity against S. pneumoniae.
The identification of clinical isolates as S. pneumoniae was based ase [21, 22] was used to sequence both strands of the inserts in all clones. Plasmid DNA preparations were denatured with alkali on optochin susceptibility, bile solubility, and the typical colony morphology. Escherichia coli strains Sure and XL1-Blue were before annealing [23] . The sequencing reagents were obtained as a kit (Sequenase version 2.0; US Biochemical, Cleveland), and obtained from Stratagene (La Jolla, CA).
Antimicrobial susceptibility tests. For the pneumococci, MICs [a- 35 S]dATP was used for labeling [24] . Initial sequence data were obtained with standard pUC primers, and subsequent data were of trimethoprim were determined by the agar dilution method as described previously [13] . To determine the susceptibility of the obtained by the primer walking technique. Sequences were assembled, edited, and analyzed with either the Wisconsin Sequence recombinant E. coli clones, a final inoculum of 10 4 cfu was delivered with a Steers-Foltz replicator onto Mueller-Hinton agarose Analysis Package (version 8; Genetics Computer Group, Madison, WI) or MacVector (Oxford Molecular Group, Campbell, CA). plates containing 100 mg/mL ampicillin and the appropriate concentration of trimethoprim. The plates were incubated at 35ЊC for BLAST [25] searches were submitted to the National Center for Biotechnology Information e-mail or World Wide Web server. 18 h. The MIC was defined as the lowest concentration of the antibiotic that inhibited visible growth.
Site-directed mutagenesis. A Pfu polymerase-based site-directed mutagenesis method was used [26] . To change Ile-100 to DHFR assays. To determine the DHFR activity of the various pneumococcal isolates, late log-phase cells grown in 2 L of ToddLeu, primers 5-CTCTACATTCTCGGTGGGAAGC and 5-GCT-TCCCACCGAGAATGTAGAG were synthesized. To mutate Hewitt broth were collected by centrifugation, washed, and resuspended to a final volume of 20 mL in 0.05 M HEPES (pH 7.3) Leu-135 to Phe, primers 5-CCCTGAAGAGTTTGACTTGTCTC and 5-GAGACAAGTCAAACTCTTCAGGG were used. The sebuffer containing 1 mM dithiothreitol. After sonification (4 times, 1 min each) and centrifugation (39,000 g, 20 min), the DHFR quences of all presumptive dfr mutants were verified by sequencing the entire DNA insert. activity in the supernatant was measured spectrophotometrically at 25ЊC by recording the decrease in absorbance at 340 nm [16, Genomic DNA analysis. The methods used to prepare agarose plugs containing genomic DNA and the subsequent analysis by 17]. The assay buffer was 0.05 M HEPES (pH 7.3) containing 1 mM dithiothreitol, 0.1 mM NADPH, 0.1 mM dihydrofolate, and digestion with SmaI and pulsed-field gel electrophoresis have been described [27, 28] . the appropriate amount of trimethoprim. NADPH oxidase activity was measured similarly but in the absence of dihydrofolate, and
Polymerase chain reaction (PCR). To amplify dfr from the pneumococci, 4 mL of an overnight culture was added to 100 mL of the results were subtracted for calculation of the DHFR activity. The protein concentration was quantitated by the Coomassie Brila mixture containing 2 U of AmpliTaq DNA polymerase (PerkinElmer, Norwalk, CT), 1.25 mM each of the four dNTPs, and liant Blue G-250 method with bovine serum albumin as the standard [18] . Specific activity is expressed as nanomoles of NADPH 0.25 mM of primers 5-AAAAGGATGGAAGCATGAC and 5-CTACGTTCCATTAGACTTCC (the start and stop codons of the converted per minute per milligram of protein.
DNA cloning. Chromosomal DNA was purified by cesium dfr coding region are underlined) in a buffer recommended by the enzyme supplier. After an initial 3-min denaturation at 95ЊC, this chloride-ethidium bromide equilibrium centrifugation, partially digested with Sau3A1, and subjected to sucrose-gradient centrifumixture was subjected to 35 cycles of amplification (Perkin-Elmer GeneAmp PCR System 9600). Each cycle consisted of a 30-s gation [19] . Appropriately sized fragments were ligated to BamHIdigested and dephosphorylated pUC18 and transformed into E.
denaturation at 94ЊC, a 30-s annealing at 55ЊC, and a 1-min extension at 72ЊC. This was followed by a final 5-min runoff at 72ЊC. coli Sure. Recombinant clones expressing trimethoprim resistance were selected on M9 agarose plates supplemented with proline Subsequently, the PCR product was ligated directly into the TA cloning vector pCR II (Invitrogen, San Diego). After transformaand thiamin plus 60 mg/mL ampicillin and 5 mg/mL trimethoprim. Standard procedures were used to subclone the trimethoprim resistion into E. coli XL1-Blue, colonies were selected on Luria-Bertani agar containing 100 mg/mL ampicillin. tance determinant from the initial isolates AP48-1 and AP188-1 [19] .
Accession numbers. The sequence data that appear herein are in the GenBank database under the accession numbers AF055720-DNA sequence analysis. The dideoxynucleotide chain-termination method [20] with modified bacteriophage T7 DNA polymer-AF055727.
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Results sequence 17-Ile-Gly-Lys-Asp-Asn-Arg-Leu-Pro-Trp-25 near the amino-terminus and amino acid homology to DHFRs from The two most common mechanisms of trimethoprim resisother bacterial species [29] . Maps of the two cloned fragments tance in bacteria are the overproduction of chromosome-enare shown in figure 1 . Further analysis showed that the 2.0-kb coded DHFR and the synthesis of a plasmid-encoded trimethoinsert from AP48 contained characteristic ''BOX'' sequences prim-resistant DHFR. If resistance to trimethoprim is caused found only in S. pneumoniae chromosomal DNA [30] . Immediby overproduction of DHFR, the specific activity of the enzyme ately upstream from the dfr gene encoding DHFR, an openin resistant isolates should be greater than that of trimethoprimreading frame (ORF 1) was detected encoding a 172-aa polysusceptible strains, and the IC 50 should not change appreciably.
peptide with striking homology to a surface-located protein We observed the opposite result for all 5 of our highly resistant from Lactobacillus rhamnosus (GenBank accession no. isolates. DHFR enzyme assays were done on the trimethoprim-AF015453) and a non-heme iron-containing ferritin from Listesusceptible R6 reference strain and 7 clinical isolates. Five of ria innocua [31] . Downstream from dfr, ORFs 3 and 4 were these isolates were highly resistant to trimethoprim (MICs of found. Whereas the hypothetical protein encoded by ORF 3 128 -256 mg/mL) and the other two were trimethoprim-interdid not show significant homology to proteins currently in the mediate (MICs of 1 -2 mg/mL). The results of these assays, databank, ORF 4 was homologous to the N-terminal end of together with the clinical and antigenic characteristics of the ATP-dependent Clp proteases [32] . strains examined, are shown in table 1. The data suggested
On the basis of the sequence analysis of plasmids pAP48-that high-level resistance was due to a trimethoprim-resistant 11 and pAP188-41, two oligonucleotide primers were designed DHFR, since the IC 50 s were 20-to 100-fold higher for the to amplify the dfr gene from all of the clinical S. pneumoniae 5 highly resistant isolates. To evaluate whether trimethoprim isolates used in this study (including AP48 and AP188) and resistance was plasmid-encoded, DNA was extracted from the the R6 reference strain. The 531-nt fragment from each PCR clinical isolates and subjected to cesium chloride -ethidium was ligated into the TA cloning vector pCR II, and the products bromide gradient centrifugation. No supercoiled plasmid DNA were subsequently transformed into E. coli strain XL1-Blue. was detected in these preparations, suggesting that the resisTransformants were selected on the basis of ampicillin resistance determinant was carried on the bacterial chromosome.
tance. Analysis revealed that clones derived from trimethoprimTo characterize the gene responsible for high-level resistance resistant S. pneumoniae imparted high trimethoprim resistance in our strains, purified chromosomal DNA from isolates AP48 on this E. coli strain, whereas clones derived from S. pneumonand AP188 was partially digested with Sau3AI and size-fraciae isolates with low trimethoprim MICs did not confer such tionated by sucrose-gradient centrifugation. Selected fragments resistance. Comparison of the DHFR amino acid sequences were ligated into the BamHI site of pUC18. After transformaencoded by the PCR-amplified dfr genes from the clinical and tion into the trimethoprim-susceptible Sure strain of E. coli, reference strains revealed that differences in only two residues clones possibly expressing the pneumococcal trimethoprim reuniformly segregated with high trimethoprim resistance. In all sistance determinant were selected on plates containing ampi-5 highly resistant strains, leucine replaced isoleucine at amino cillin and 5 mg/mL trimethoprim. Highly trimethoprim-resistant acid position 100, and phenylalanine replaced leucine at posiclones (MIC §128 mg/mL) AP48-1 and AP188-1 were obtion 135 (figure 2). Both of these amino acid changes reflect tained, which contained plasmids with 10.9-and 3-kb inserts, a single-base change in the dfr gene. The trimethoprim-intermerespectively. Subcloning after HindIII digestion yielded the diate strains AP71 and AP92 did not show this substitution. trimethoprim-resistant strains AP48-11 and AP188-41, which
To assess the individual role of amino acid residues 100 and had inserts of 2.0 and 1.3 kb, respectively. Sequence analysis 135 in trimethoprim resistance, the dfr gene derived from the of these two clones revealed that both pneumococcal DNA trimethoprim-susceptible R6 reference strain was modified by site-directed mutagenesis to create three new proteins. DNA inserts encoded a 168-aa polypeptide with the DHFR signature sequence analysis confirmed that each of the three new proteins methoxazole has been used extensively for almost 30 years. As a result, trimethoprim resistance has developed among virtucorresponded to the original R6 DHFR with one of the following mutations: isoleucine-100 to leucine (Ile100Leu), leucineally all clinically important bacterial species, and the proportion of trimethoprim-resistant strains has reached high levels in 135 to phenylalanine (Leu135Phe), or isoleucine-100 to leucine combined with leucine-135 to phenylalanine (Ile100Leu and many countries [33] . Resistance to trimethoprim is either plasmidborne or chromosome-encoded, with the former being the Leu135Phe). The mutant and the parental R6 plasmids were transformed into trimethoprim-susceptible E. coli, and the most frequent and clinically significant. Indeed, since the first description of plasmid-mediated trimethoprim resistance in transformants were tested for trimethoprim susceptibility by the agar dilution method. As shown in table 2, only DHFR 1972 [34] , at least 16 types of transferable plasmidborne trimethoprim resistance determinants have been recognized in constructs containing a leucine residue at position 100 conferred trimethoprim resistance to the transformed E. coli. These gram-negative and 1 in gram-positive bacteria [33, 35] . Because one of the most common trimethoprim resistance deterresults indicate that a single substitution of leucine for isoleucine at position 100 of S. pneumoniae DHFR results in trimethminants is associated with the Tn7 transposon, this type is also frequently found integrated into the chromosome. Other oprim resistance.
chromosomal changes associated with trimethoprim resistance Discussion have been described in E. coli and Haemophilus influenzae. In Because of its broad spectrum of antibacterial activity, good these cases, resistance was due to an altered promoter, resulting tolerance, and low cost, the combination of trimethoprim-sulfain overproduction of the chromosome-encoded DHFR [36, 37] . Changes within the dfr coding region that confer resistance appear to be rare, but examples have recently been reported laboratory mutants was probably due to increased levels of dfr of many proteins. Provided that the amino acid substitution does not have a negative effect on survival, the mutation retranscription or to changes in antifolate uptake [40, 41] . In this report, we show that a single mutation in the chromosomal dfr mains silent and will continue to be carried by the bacteria. The presence of antibacterials in a given environment provides gene, which results in the conservative replacement of isoleucine-100 by leucine, is associated with trimethoprim resistance selective pressure, which results in the enrichment of strains resistant to treatment. The 5 highly trimethoprim-resistant cliniin a variety of S. pneumoniae clinical isolates from the Washington, DC, area. These data are consistent with those of Adrian cal isolates we describe herein may represent an example of this phenomenon and highlight the dangers associated with the and Klugman who, while our manuscript was in preparation, reported that the same change is responsible for trimethoprim overuse of antibacterial agents [43, 44] . The effect of the conservative change of isoleucine-100 to resistance in S. pneumoniae isolates from South Africa [42] . These authors propose that resistance is acquired by transforleucine on the resistance of the pneumococcal DHFR to trimethoprim can be explained by comparison to the 159-aa mation of sensitive cells with DNA from another, as-yet-unidentified species, followed by recombination. On the basis of DHFR from E. coli. Using the DHFR signature sequence as an index, a Clustal-W alignment of the enzymes from S. pneuthe observation that two distinct codons are used for leucine-100 (CTC and CTT), as well as additional sequence diversity moniae R6 and E. coli K12 [45] shows that 57 (36%) amino acids are identical and 34 (21%) are similar. Importantly, amino among the DHFRs in our resistant isolates, we propose that the origin of trimethoprim resistance can be explained by enviacid residues within the E. coli DHFR catalytic pocket that participate in the formation of hydrogen bonds to either dihyronmental selection of naturally occurring mutants. As a result of spontaneous mutations, bacterial populations harbor variants drofolate or trimethoprim are conserved in the S. pneumoniae identified between protonated trimethoprim and DHFR, while four hydrogen bonds are involved in the binding of the natural dihydrofolate substrate [46, 47] . In this context, the only difference between the hydrogen bonding patterns within the active
